These typical insulinomas become symptomatic very early when they are small in size (< 2 cm) and are characterized by somatic YY1 mutations in about 30% of cases, or recurrent somatic amplifications (in particular chromosome 7 amplifications) (39). Here, YY1 is linked to pancreatic insulinoma.